If you are on Medicare and trying to figure out the cost of Eliquis, you have probably seen the headline: Medicare negotiated the price down to $231. Then you got to the pharmacy and were charged something else entirely. That gap is real, it is common, and almost nobody explains it plainly. SunnyPharma built this guide from official Medicare and manufacturer sources to do exactly that — show what Eliquis (apixaban) actually costs on Medicare in 2026, why your pharmacy price may differ from the negotiated number, and the concrete steps that lower what you pay.
The single most important thing to know up front: the $231 figure is what the government pays, not necessarily your copay — and there are several legitimate ways to bring your cost down, including a new annual cap on what you can spend. For decisions about your treatment, your clinician and your Part D plan are the right sources; this guide helps you ask the right questions.
- $231 is the negotiated price (what Medicare pays), not automatically your copay
- Most enrollees pay about $35–$58/month once past the deductible — roughly $58 on a 25% coinsurance plan, or $35–$47 on a flat-copay preferred tier
- New annual cap: your total Part D out-of-pocket is limited to $2,100 for the year
- Extra Help (LIS) can cut a brand copay to $12.65 per prescription or less if you qualify
- Coupons don’t work with Medicare — but the free trial card and the payment plan do
- Never stop over cost: Eliquis has a boxed warning about clot and stroke risk if stopped early
Is the $231 Negotiated Price What You Actually Pay?
Usually not directly — and this is the heart of the confusion. The $231 is the Medicare-negotiated Maximum Fair Price for a 30-day supply of Eliquis, effective January 1, 2026, under the Inflation Reduction Act. It is the amount Medicare pays. What you pay at the counter is set by your individual Part D plan, and it moves through the year depending on which coverage phase you are in.
Think of your Part D year in phases. First you may owe a deductible (up to $615 in 2026) before your plan starts sharing costs — and during that phase your out-of-pocket can look much higher than $231. After the deductible, you pay your plan’s copay or coinsurance for Eliquis: on plans that use coinsurance that is 25% of the negotiated price, about $58 a month, while plans that place Eliquis on a preferred-brand tier often charge a flat copay closer to $35 to $47. And once your total spending hits the $2,100 annual cap, you pay nothing more for covered drugs for the rest of the year.
Why Your Pharmacy Charges More — and How to Diagnose It
If your pharmacy quote is higher than you expected, it is almost always one of a few specific things — and you can work through them in order. This is the part most cost guides skip.
- You are still in the deductible phase. Early in the calendar year, before you have met your plan’s deductible (up to $615), you may pay the full negotiated price. This resets every January, which is why Eliquis often feels most expensive in the first months of the year.
- Eliquis is on a higher formulary tier in your plan. Two plans can cover the same drug at very different copays. Ask your plan which tier Eliquis is on and what the copay or coinsurance is for that tier.
- You are at an out-of-network or non-preferred pharmacy. Many Part D plans have “preferred” pharmacies with lower copays. The same prescription can cost less across the street.
- Your plan changed for 2026. Plans send an Annual Notice of Change each fall. If your tier or copay shifted, your cost did too.
The one call to make: phone the member-services number on your Part D card and ask three things — “Which coverage phase am I in right now?”, “What tier is Eliquis on, and what’s my copay in that tier?”, and “Is there a preferred pharmacy where it costs less?” Those three answers explain almost any surprising price.
A note from the reviewer
If the pharmacy number shocks you, don’t walk away and don’t skip the dose — call your plan and ask which phase you’re in. Nine times out of ten it’s the January deductible, and it drops once that’s met. The worst thing you can do with a blood thinner is stop it over a price that was about to come down anyway.
— Dr. Aun-Yeong Chong, MBBS, MD, MRCP, cardiologist
How to Lower the Cost of Eliquis on Medicare
Several routes genuinely work for Medicare beneficiaries — here they are in roughly the order most people should consider them. 2026 added real protection that did not exist before.
1. Lean on the new Part D out-of-pocket cap
This is the biggest change. Your total out-of-pocket for all Part D drugs is now capped at $2,100 for the year. Once you reach it, Eliquis and your other covered drugs cost you $0 for the rest of the year. For someone taking Eliquis long-term for atrial fibrillation, this caps your annual exposure in a way the old system never did.
2. Apply for Extra Help (Low-Income Subsidy)
If your income and resources are limited, Extra Help can reduce a brand-name copay to $12.65 per prescription or less — and to $4.90 or less at the lowest income levels. You apply through the Social Security Administration. Check eligibility even if you are unsure — the resource limits exclude your home and car, so more people qualify than expect to. For many beneficiaries struggling with Eliquis cost, this is the highest-impact single step.
3. Use the Medicare Prescription Payment Plan
This 2026 option lets you spread your out-of-pocket costs across the year in monthly installments instead of paying a large amount at once. It does not lower your total, but it smooths out an expensive deductible month. Enrollment is voluntary and free, has no income requirement, and is set up through your Part D plan.
4. Get the Eliquis Free Trial Offer Card
Unlike the copay card, the manufacturer’s Free Trial Offer Card is available to Medicare patients, because a free trial does not subsidize a purchase and so does not run afoul of the anti-kickback rules. It provides an initial supply at no cost. Treat it as a one-time starter, not an ongoing solution — you will still need the pathways above for refills.
5. Compare plans at Open Enrollment
During Open Enrollment (October 15 to December 7), use Medicare’s Plan Finder to compare how different Part D plans cover Eliquis. Because tier placement drives your copay, switching to a plan that tiers Eliquis more favorably can change your annual cost meaningfully.
Never stop taking Eliquis because of cost. Eliquis carries an FDA boxed warning that stopping it early raises the risk of blood clots and stroke. If you cannot afford it, talk to your clinician or pharmacist before skipping or stopping doses — one of the pathways above almost always fits, and a clinician can discuss whether a different, lower-cost anticoagulant is appropriate rather than going without treatment.
What Doesn’t Work: Coupons and Copay Cards
One route you will see advertised everywhere is closed to you on Medicare: the manufacturer copay coupon or savings card. Federal anti-kickback law prohibits using a drug manufacturer’s copay assistance if you have Medicare, Medicaid, or other government insurance. Those cards are built for people with commercial (private) insurance only. If a site lists “manufacturer coupons” as a way to save on Eliquis with Medicare, that advice is simply wrong.
There is one nuance worth knowing. A pharmacy discount card (such as SingleCare or GoodRx) is different from a manufacturer copay card — it offers a cash price instead of using your insurance. You can legally use one, but only by paying cash for that fill and not running it through Medicare, and what you pay that way does not count toward your Part D out-of-pocket cap. For most Medicare beneficiaries, the negotiated price plus the cap is the better route; the discount card is a niche tool for specific situations.
Searching for a coupon and hitting this wall is exactly why this page exists. If that is you, the next step isn’t another coupon site — it’s checking your Extra Help eligibility and confirming your plan’s Eliquis tier. Those move your real cost; the coupon never could.
If You’re Not Yet on Medicare — or Waiting on a Generic
If you are uninsured or between coverage, the route is different from the Medicare pathways above. The Bristol Myers Squibb Patient Assistance Foundation provides Eliquis at no cost to qualifying patients who are uninsured and meet income limits. That program is generally not for Medicare beneficiaries — which is the whole reason the Medicare-specific pathways exist as a separate track.
As for a cheaper generic apixaban: do not count on it soon, and be wary of confident dates. Generic apixaban was FDA-approved back in December 2019, but patent settlements set April 1, 2028 as the earliest broad US launch, subject to ongoing litigation. Until a generic is broadly stocked, the reliable cost levers for Medicare patients remain the negotiated price, the Part D cap, and Extra Help — not waiting.
Related Anticoagulant Guides
For the bigger picture on anticoagulant costs and the coupon question specifically, start here.
Frequently Asked Questions
How much does Eliquis cost on Medicare in 2026?
It depends on your Part D plan and where you are in the year. A Medicare-negotiated price of $231 for a 30-day supply took effect January 1, 2026, but that is what the government pays, not automatically your copay. In the initial coverage phase, most enrollees pay about $35 to $58 per month for Eliquis: roughly $58 on plans that charge 25% coinsurance on the $231 price, or about $35 to $47 on plans that place it on a preferred-brand tier with a flat copay. Before that, you may owe a deductible of up to $615, and once your total Part D spending reaches the $2,100 annual cap, covered drugs cost you nothing for the rest of the year.
Is the $231 Eliquis negotiated price what I actually pay?
Usually not directly. The $231 figure is the Medicare-negotiated Maximum Fair Price — what the government pays for a 30-day supply starting in 2026. What you pay at the pharmacy is set by your specific Part D plan: your deductible, your plan’s formulary tier for Eliquis, and your coinsurance or copay. That is why some patients see headlines about $231 but are still charged more at the counter, especially early in the year before the deductible is met. Your annual out-of-pocket is capped at $2,100 across all Part D drugs.
Why is my pharmacy charging more than $231 for Eliquis?
A few reasons. If you have not yet met your Part D deductible (up to $615 in 2026), you may pay the full negotiated price until coverage kicks in. After the deductible, your cost is your plan’s copay or coinsurance for Eliquis’s formulary tier — about 25% of $231 (roughly $58) on a coinsurance plan, or a flat copay commonly around $35 to $47 on a preferred tier. The negotiated price sets what Medicare pays, not your share. If the price seems wrong, ask your plan which coverage phase you are in and what tier Eliquis sits on, and confirm you are using a pharmacy in your plan’s preferred network.
How can I get help paying for Eliquis on Medicare?
Several legitimate routes exist. The biggest 2026 change is the Part D out-of-pocket cap of $2,100, which puts a hard ceiling on your yearly cost. If your income is limited, Medicare Extra Help (the Low-Income Subsidy) can cut your brand copay to $12.65 per prescription or less. The Medicare Prescription Payment Plan lets you spread costs across the year in monthly installments. The Eliquis Free Trial Offer Card is available even to Medicare patients. Note that manufacturer copay coupons cannot be used with Medicare.
Can I use Medicare Extra Help for Eliquis?
Yes, if you qualify. Medicare Extra Help, also called the Low-Income Subsidy (LIS), helps people with limited income and resources pay Part D costs. In 2026 it caps the copay for a brand-name drug like Eliquis at $12.65 per prescription for people between 100% and 150% of the federal poverty level, and $4.90 or less at lower incomes. You apply through the Social Security Administration. It is worth checking eligibility even if you are unsure, because the resource limits exclude items like your home and car. For many Medicare beneficiaries struggling with Eliquis cost, Extra Help is the single highest-impact step.
Can I use an Eliquis coupon or copay card with Medicare?
No. Federal anti-kickback law prohibits using a manufacturer copay coupon or savings card if you have Medicare, Medicaid, or other government insurance. Those cards are only for people with commercial (private) insurance. Medicare beneficiaries lower Eliquis costs through the negotiated price, the Part D out-of-pocket cap, Extra Help, the Medicare Prescription Payment Plan, and the manufacturer’s free trial card, which is allowed for government-insured patients because a free trial is not a purchase subsidy.
What is the Medicare Prescription Payment Plan and does it lower my Eliquis cost?
The Medicare Prescription Payment Plan (M3P) is a 2026 option that lets you spread your out-of-pocket drug costs across the calendar year in monthly installments instead of paying a large amount at the pharmacy at once. It does not reduce your total cost for the year — the most you would pay across the year is still capped at $2,100 — but it can make an expensive month, such as when you are still meeting your deductible, far more manageable. Enrollment is voluntary, free, has no income requirement, and you sign up through your Part D plan.
Will a generic apixaban lower my Medicare cost soon?
Not in the immediate term, and the timing is contested. Generic apixaban was FDA-approved back in December 2019, but patent settlements set April 1, 2028 as the earliest broad US launch, subject to ongoing litigation. Until a generic is broadly available, the reliable cost levers for Medicare beneficiaries are the negotiated price, the Part D out-of-pocket cap, and Extra Help, rather than waiting on a generic.
What happens if I stop taking Eliquis because of cost?
Stopping Eliquis because of cost is dangerous. Eliquis carries an FDA boxed warning that stopping it early raises the risk of blood clots and stroke. If cost is the barrier, talk to your clinician or pharmacist before skipping or stopping doses, and use the Medicare pathways first: the negotiated price, the Part D out-of-pocket cap, Extra Help, the payment plan, and the free trial card. A clinician can also discuss whether a different, lower-cost anticoagulant is appropriate rather than going without treatment.
How we reviewed this article:
Richard Boehme researched and wrote this guide using official Medicare and government sources — CMS’s Final CY2026 Part D Redesign Program Instructions, Medicare.gov cost and payment-plan documentation, the CMS Low-Income Subsidy limits, the Social Security Administration, and the Eliquis manufacturer program terms. Every dollar figure traces to one of those sources. Dr. Aun-Yeong Chong, a cardiologist, reviewed the clinical content — including the boxed-warning caution against stopping anticoagulation for cost.
Read our editorial policy →Sources & References
- CMS — Final CY 2026 Part D Redesign Program Instructions (three-phase benefit; 25% initial-coverage coinsurance; $2,100 out-of-pocket threshold): cms.gov
- CMS — Medicare Drug Price Negotiation Program, Negotiated Prices for 2026 (Eliquis Maximum Fair Price $231 / 30-day): cms.gov
- Medicare.gov — Costs for Medicare drug coverage (Part D deductible up to $615; formulary tiers; the out-of-pocket cap): medicare.gov
- CMS — Calendar Year 2026 Resource and Cost-Sharing Limits for the Low-Income Subsidy (brand copay $12.65 at 100–150% FPL; $4.90 at or below 100% FPL): cms.gov
- Social Security Administration — Extra Help with Medicare prescription drug costs: ssa.gov
- Medicare.gov — Medicare Prescription Payment Plan (voluntary, free, no income test; installments): medicare.gov
- Medicare.gov — Find a Medicare plan (Plan Finder): medicare.gov
- KFF — Eliquis direct-to-consumer price vs. Medicare-negotiated price ($231) analysis: kff.org
- Eliquis (apixaban) — official pricing and government-insured patient support, incl. Free Trial Offer Card (Bristol Myers Squibb): eliquis.bmscustomerconnect.com
- HHS Office of Inspector General — copay coupons and the federal anti-kickback statute: oig.hhs.gov
- FDA — Eliquis (apixaban) Prescribing Information (boxed warning): accessdata.fda.gov